Navigation Links
NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil®
Date:6/5/2011

4

4

4Previous Platinum Regimens  1

13%

35%

24%  2

56%

24%

39%  3

25%

18%

21%  4+

6%

24%

15%Prior bevacizumab

6%

24%

15%Prior gemcitabine

56%

59%

58%Prior taxane

100%

100%

100%TABLE 2. Efficacy Results: Objective Response Rates by RECIST and GCIG in Subpopulation Receiving Prior Treatment with PLDNKTR-102NKTR-102145 mg/m2  q14d145 mg/m2q21dRECISTN (evaluable)16

14Confirmed + Unconfirmed

4 (25%)

4 (29%)Confirmed

3 (19%)

3 (21%)Duration of Confirmed Response (months, range)

4.2 (3-14)

4.4 (3-9)GCIGN (evaluable)

16

17Confirmed + Unconfirmed

8 (50%)

6 (35%)Confirmed

6 (38%)

6 (35%)CA-125N (evaluable)

15

14Confirmed

6 (40%)

5 (36%)*Only patients with measurable disease/CA-125 at baseline were considered evaluable.TABLE 3. Safety Results in Subpopulation Receiving Prior Treatment with PLDMost Common Drug-related Grade 3 and 4

Adverse Events > 5% or event of interest

N (%) NKTR-102

145 mg/m2

q14d

N=16

NKTR-102

145 mg/m2

q21d

N=17Grade 3

Grade 4

Grade 3

Grade 4Diarrhea

5 (31%)

0

3 (18%)

0Hypokalemia

5 (31%)

1 (6%)

0

0Nausea

5 (31%)

0

1 (6%)

0Dehydration

3 (19%)

0

1 (6%)

0Fatigue

1 (6%)

0

3 (18%)

0Vomiting

4 (25%)

0

0

0Neutropenia

1 (6%)

0

1 (6%)

1 (6%)Anaemia

2 (12.5%)

0

0

0Decreased appetite

1 (6%)

0

1 (6%)

0Hyponatraemia

2 (13%)

0

0

0Lymphophenia

1 (6%)

0

1 (6%)

0Note: There wa
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
2. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
3. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
4. NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients
5. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
8. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
9. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
10. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
11. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Quebec , June 18, 2013 Valeant ... TSX: VRX) (the "Company") announced today that VPII Escrow ... the Company, has launched its offer of approximately $3.2 ... "Notes").  The Notes will be due in 2021 and ... The Company intends to use the net proceeds ...
(Date:6/18/2013)... N.J. , June 18, 2013  Actavis, Inc. (NYSE: ... Actavis") has filed with the U.S. Securities and Exchange Commission ... Actavis, proposed acquisition of Warner Chilcott plc (NASDAQ: ... of Actavis and Warner Chilcott (the "Form S-4"). ... and Warner Chilcott have entered into a definitive ...
(Date:6/18/2013)... 18, 2013  Millennium HealthCare Inc. (OTC Pink: ... an exclusive 25-year Supply and Distribution agreement for ... ("EWC") for its Distance Monitored Physical Therapy Program ... therapy program is a critical element in reducing ... Chris Amandola , president, Millennium HealthCare Inc.  ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3
(Date:6/19/2013)... that block the body,s system for repairing damage to ... As unlikely as it may seem, those compounds are ... cancers driven by a mutation in BRCA, a gene ... carries the mutation. The compounds, termed PARP inhibitors, are ... edition of Chemical & Engineering News . C&EN ...
(Date:6/19/2013)... Louisiana State University have developed a method for identifying ... on understanding the genetic interaction between single nucleotide polymorphisms ... cancer,s aggressiveness to avoid unnecessary radical treatment. , ... PLOS ONE in April. , According to the ... cancers and 9 percent of cancer deaths. It is ...
(Date:6/19/2013)... Alternatives, a revolutionary new treatment facility ... using drugs while allowing them to continue drinking alcohol. ... Alternatives, believe that abstinence-only approaches force people to wait ... that this approach hurts instead of helping. It ... States need treatment for addiction but only 3 million ...
(Date:6/19/2013)... Washington (PRWEB) June 19, 2013 ... physicians deem it medically necessary, according to a ... and Child Health Journal. The results of this ... for more than a decade – that trying-to-conceive ... and maintaining a healthy body weight. Fairhaven Health ...
(Date:6/19/2013)... Menopause International , suggests that post-menopausal women ... satisfying sex compared to their European and North ... to access appropriate treatment for a common, taboo ... called the CLarifying vaginal atrophy,s impact On SEx ... women with vaginal atrophy are more likely to ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2
... Angeles, study the diet patterns in 52 normal weight people ... normal people generally ate more fruits and fibres than their ... the Journal of the American Dietetic Association stated that the ... and fruit intake, plays a role in the development of ...
... were related to drinking have more than doubled in Britain in ... yesterday by the Office for National Statistics (ONS) revealed has revealed ... in 2004. The statistics also showed that the alcohol related deaths ... is increasing in recent years. ,It was explained that ...
... in North Carolina and Virginia found evidence of pesticide ... call for pesticide safety training for workers’ spouses. ... Wake Forest University School of Medicine report that urine ... exposure than had been found in similar studies elsewhere. ...
... smoking in enclosed places and has put the draft regulation ... said that the government wanted to know about the people's ... and also said that it would be nice if the ... the Tories say that the plan would be expensive and ...
... be mandatory on all tobacco products soon failing which ... ,Other health warnings that could appear on ... pictorial representation of ill-effects of tobacco use and a ... headed by Anbumani Ramadoss, who has been a staunch ...
... has signed a memorandum of understanding (MOU) with the Clinton ... of affordable//, high- quality drugs as well as diagnostics for ... at the Presidential Villa with Nigerian President Olusegun Obasanjo and ... to Nigeria, as witnesses. ,According to the agreement, ...
Cached Medicine News:Health News:Better Weight Management Can be Achieved By Increased Intake Of Fibre & Fruits 2Health News:Research Documents Children’s Exposure to Pesticide 2
... Size: 3.0 x 7.5 x 80 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... Size: 4.0 x 80 mm. Storz ... line designed by Harvey A. Lincoff, ... cell sponge which is non-toxic and ... edges to minimize scleral intrusion. These ...
For use with E5381 700 Circling Band (240 style). 1.65 mm diameter, 30.0 mm long....
For use under silicone strips E5381 610, E5381 611 and E5381 710. Indications: When higher buckle is required. Overall length: 6.1 mm....
Medicine Products: